12th Mar 2012 07:00
Notice of Results
LONDON, UK, 12 March, 2012 - SkyePharma PLC (LSE: SKP) will announce its preliminary results for the year ended 31 December 2011, on Thursday 22 March 2012. A recording of the event will be available on the Company's website at www.skyepharma.com.
For further information please contact:
SkyePharma PLC | |
Peter Grant, Chief Executive Officer | +44 207 881 0524 |
FTI Consulting | |
Jonathan Birt /Sue Quigley | +44 207 831 3113 |
About SkyePharma
Using its proprietary drug delivery technologies, SkyePharma develops new formulations of known molecules to provide a clinical advantage. The Group has eleven approved products in the areas of oral and topical delivery as well as important license and revenue-generating arrangements in inhalation and injectable technologies. The Group's products are marketed throughout the world by leading pharmaceutical companies. For more information, visit www.skyepharma.com.
Related Shares:
SKP.L